2023
|
Invention
|
Compounds, devices, and uses thereof.
The present invention provides compounds, e.g., compounds ... |
|
Invention
|
Engineered cells and implantable elements for treatment of disease. Described herein are engineer... |
|
Invention
|
Hydrogel capsules comprising covalently photocrosslinked polysaccharides and islet cells. Describ... |
|
Invention
|
Covalently crosslinked polysaccharides and methods of use thereof. Described herein are hydrogel ... |
|
Invention
|
Covalently photocrosslinked polysaccharides and methods of use thereof. Described herein are poly... |
|
Invention
|
Modified polysaccharide polymers and related compositions and methods thereof. Described herein a... |
|
Invention
|
Compositions, devices and methods for treating cns disorders. Described herein are BBB-transporti... |
|
Invention
|
Therapies for mucopolysaccharidosis type 6. Described herein are ARSB fusion proteins, polynucleo... |
2022
|
Invention
|
Compositions for cell-based therapies and related methods.
Described herein are hydrogel capsule... |
|
Invention
|
Compositions for cell-based therapies and related methods. Described herein are hydrogel capsule ... |
|
Invention
|
Genetically modified human cell lines and uses thereof.
Described herein are genetically modifie... |
|
Invention
|
Genetically modified human cell lines and uses thereof. Described herein are genetically modified... |
|
Invention
|
Compositions, devices and methods for treating mps vi disease.
Described herein are mammalian ce... |
|
Invention
|
Compositions, devices and methods for treating mps vi disease. Described herein are mammalian cel... |
|
Invention
|
Compositions, devices and methods for inducing antigen-specific immune tolerance.
Described here... |
|
Invention
|
Compositions, devices and methods for treating immune-mediated inflammatory diseases.
Described ... |
|
Invention
|
Compositions, devices and methods for treating immune-mediated inflammatory diseases. Described h... |
|
Invention
|
Compositions, devices and methods for inducing antigen-specific immune tolerance. Described herei... |
|
Invention
|
Biocompatible devices for cell-based therapies and related methods. Described herein are implanta... |
2021
|
Invention
|
Heteroaryl and heterocyclyl compounds.
Described herein are compounds of Formulas (I), (II), and... |
|
Invention
|
Heteroaryl and heterocyclyl compounds. Described herein are compounds of Formulas (I), (II), and ... |
|
Invention
|
Genetically modified cell lines expressing an exogenous substance and uses thereof.
Described he... |
|
Invention
|
Genetically modified cell lines expressing an exogenous substance and uses thereof. Described her... |
|
Invention
|
Compositions, devices and methods for inducing immune responses to infectious agents.
Described ... |
|
Invention
|
Compositions, devices and methods for inducing immune responses to infectious agents. Described h... |
2020
|
Invention
|
Compounds, polymers, devices, and uses thereof.
Described herein are compounds of Formula (I), p... |
|
Invention
|
Compounds, polymers, devices, and uses thereof. Described herein are compounds of Formula (I), po... |
|
Invention
|
Apparatuses and methods for formation of particles.
Described herein are apparatuses and methods... |
|
Invention
|
Apparatuses and methods for formation of particles. Described herein are apparatuses and methods ... |
|
Invention
|
Monoclonal cell lines expressing an exogenous substance and uses thereof.
Described herein are g... |
|
Invention
|
Monoclonal cell lines expressing an exogenous substance and uses thereof. Described herein are ge... |
|
Invention
|
Methods of evaluating small molecule-modified polymers in compositions.
Described herein are met... |
|
Invention
|
Methods of evaluating polypeptide-modified polymers in compositions.
Described herein are method... |
|
G/S
|
Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharma... |
|
G/S
|
Chemical, pharmaceutical, biopharmaceutical and biomedical
agents for medical use, namely, pharm... |
|
Invention
|
Compositions, devices, and methods for factor vii therapy.
Described herein are RPE cells engine... |
|
Invention
|
Compositions, devices, and methods for treating fabry disease.
Described herein are RPE cells en... |
2019
|
Invention
|
Implantable devices for cell therapy and related methods.
Described herein are implantable devic... |
|
G/S
|
Chemical agents for coating of medical devices and medical
materials; reagents for research purp... |
|
G/S
|
Chemical agents for coating of medical devices and medical materials for use in the research, dis... |
|
Invention
|
Methods, compositions, and implantable elements comprising stem cells.
Described herein are cell... |
2018
|
G/S
|
Chemical agents for coating of medical devices and medical materials; reagents for research purpo... |
|
G/S
|
Chemical agents for coating of medical devices, medical materials, and for encapsulating pharmace... |
|
G/S
|
Chemical agents for scientific and research use, namely, small molecules for purposes of preventi... |
|
G/S
|
Chemical agents for scientific and research use, namely, small molecules in the nature of chemica... |
|
G/S
|
Chemical agents for scientific and research use, namely,
small molecules in the nature of chemic... |
2017
|
G/S
|
Chemical agents for coating of medical devices, medical
materials, and for encapsulating pharmac... |
|
G/S
|
Chemical agents for scientific and research use, namely,
small molecules; chemical agents for co... |
2015
|
G/S
|
Agents for scientific and research use, namely, small molecules; chemical agents for coating of m... |